We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Catena Group Plc | LSE:CTNA | London | Ordinary Share | GB00BYV31355 | ORD 1P |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
87.00 | 91.00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
- |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
- | O | 0 | 89.00 | GBX |
Date | Time | Source | Headline |
---|---|---|---|
28/12/2023 | 07:00 | RNSNON | Insig AI Plc Inclusion within UN Environment Programme Tool |
30/10/2023 | 07:00 | RNSNON | Insig AI Plc New Product Launch |
Catena (CTNA) Share Charts1 Year Catena Chart |
|
1 Month Catena Chart |
Intraday Catena Chart |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|
Top Posts |
---|
Posted at 10/5/2021 09:32 by hiddendepths You can also get a price from any broker you use - I tried a dummy buy and sell on II but they're not giving a price much inside the quote. I guess the MMs are staying off the bid for now as they're wary of profit-takers! The dummy sell showed 87.9 so I guess the placees are generally looking longer term for much more! |
Posted at 06/5/2021 13:22 by pj 1 I've communicated with a couple of wealth/ pension managers over the last week. Whilst CTNA is far too risky in isolation for their own investments, both did report back to me that the target market is substantial.The slightest gain of traction in to this market would be a major catalyst as investors add 2+2. |
Posted at 06/5/2021 08:41 by parsnip1 Given the niche sectors there could be many funds. Profit share on upside with no financial downside risk is limited only by the size of the funds. I'm rather heartened by this source of earnings. Cannot be long before additional meaningful investors take a look at this. Fascinating |
Posted at 30/4/2021 16:17 by slartybartfaster I'm concluding the IMC is a bad omen. My first experience was with OPTI, there was a sell off after it. It's not recovered. Now CTNA same thing is happening. I'm told it may just be legacy investors selling after suspension. |
Posted at 27/4/2021 10:38 by hiddendepths It's only a matter of time until this gets discovered by the press and investment mags/tipsheets. Liquidity is not very high so the shares could well respond explosively. Hopefully everything is up and running, name change, share issues and the like, before it all kicks off.IMHO of course. As ever, dyor! |
Posted at 26/4/2021 16:38 by parsnip1 Bound to be some old shareholders taking advantage of their entry price however once the acquisition/renaming complete I can foresee a reclassification in terms of expectations. Nice and steady wins the race |
Posted at 26/4/2021 15:03 by shrewdmole Before that last little rise the rsp was very one sided. Only 3.5k shares available quoted at ANY price but all mm on the bid on the rsp totalling about 60k. |
Posted at 22/4/2021 17:31 by divmad Same here. The growth in AI-based portfolio management tools and applications should be immense over the next decade, so there might be a first mover advantage for an outfit like CTNA. I would have liked to see part of their revenue model with some leverage to aum, but then, they are hoping to sell vertically through a fund management group to embrace all asset classes, which should generate extra licenses and revenues. In at the ground level here, for better or worse. |
Posted at 21/4/2021 09:57 by 74tom Not intending to put a downer on things here, however having read the prospectus I can't understand the valuation here at all. Would have been nice to have had more than 30 minutes to look before it listed this morning...Page 26 of the prospectus; "Insight does not currently have any patents or pending patent applications in respect of any of its products." I'm amazed that they haven't even got ANY pending patents prior to a public listing, they've had the last 12 months+ to at least get something in motion. What are the barriers to someone with a bit of money copying their SaaS model? With regard to the earlier comparison to RENX, they have an exclusive global license to patented blood based biomarker technology which provides a genuine barrier to entry for any competitor. Not sure I see any barriers at all here? Also, from the C3 AI prospectus; "Strategic Competitive IP Advantage We enjoy a rich patent portfolio that is a substantial competitive advantage, both offensive and defensive, in the Enterprise AI market—most notably, our most recently issued U.S. patents (No. 10,817,530 and No. 10,824,634) which were granted for systems, methods, and devices for an enterprise AI and internet-of-things platform. Our patent portfolio covers the key capabilities of our model-driven architecture that are the foundation of our highly differentiated technology. This includes methods, systems, and devices for data aggregation and unification, times-series data processing, data abstraction, machine learning implementation, and much more." Clearly they on a different scale with a C3 AI sporting a $6b cap (and $181m of revenue) vs the current $110m (and £1m revenue) of CTNA, however the fact CTNA don't have a single pending patent application has to be a major weakness. What stops someone with even moderately deep pockets simply copying their ideas? It's hardly 'proprietary' without a single patent! Considering they are pitching to asset managers, they are playing a dangerous game. In March 2020 CTNA bought 9.1% of Insight for £1.5m, valuing at £16.5m, what has happened in the interim to justify the 400% increase in market cap to £80m? It looks way over cooked to me. |
Posted at 22/3/2021 08:46 by ltinvestor I suppose a “premium” |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions